Materials & Resources » Chemicals | Porton Fine Chemicals Ltd.

Porton Fine Chemicals Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
731
983
1,015
1,312
1,166
1,168
Cost of Goods Sold (COGS) incl. D&A
456
636
702
816
777
812
Gross Income
275
347
313
497
389
356
SG&A Expense
136
176
153
237
215
239
EBIT
129
156
149
242
169
112
Unusual Expense
-
-
-
-
5
12
Non Operating Income/Expense
11
1
2
3
1
72
Interest Expense
6
17
30
40
50
64
Pretax Income
120
148
132
205
115
133
Income Tax
20
25
26
43
20
21
Equity in Affiliates
-
-
-
-
-
-
Consolidated Net Income
101
123
106
162
94
111
Net Income
100
125
110
171
107
124
Net Income After Extraordinaries
100
125
110
171
107
124
Net Income Available to Common
100
125
110
171
107
124
EPS (Basic)
0.25
0.31
0.27
0.40
0.26
0.26
Basic Shares Outstanding
394
406
409
425
420
479
EPS (Diluted)
0.25
0.31
0.27
0.40
0.26
0.26
Diluted Shares Outstanding
394
406
409
425
420
479
EBITDA
147
185
205
321
284
235
Other Operating Expense
10
15
12
18
5
5
Non-Operating Interest Income
-
1
1
1
2
24
Minority Interest Expense
1
3
5
9
13
13

About Porton Fine Chemicals

View Profile
Address
Fangzheng Avenue
Chongqing Chongqing 400714
China
Employees -
Website http://www.porton.cn
Updated 07/08/2019
Porton Pharma Solutions Ltd. engages in the research and development and manufacture of pharmaceutical products and active pharmaceutical ingredients. It offers anti-viral, anti-diabetic, anti-hypertensive, anti-cancer, analgesic, hypolipidemic, and antibacterial drug treatment. The company was founded on July 7, 2005 and is headquartered in Chongqing, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.